CURRENT POSITION:
Senior Investigator, Section on Cellular Neurobiology, Laboratory of Developmental Neurobiology, NICHD
EDUCATION AND TRAINING:
Dr Loh received her BSc (Hons) in Biochemistry from University College Dublin, Ireland, and her PhD in Molecular Biology from The University of Pennsylvania, Philadelphia, PA, USA. She did her postdoctoral work with Dr Harold Gainer at NIH and at the Max Plank Institute in Germany.
RESEARCH INTERESTS:
Dr Y Peng Loh is the head of the Section on Cellular Neurobiology, Program on Developmental Neuroscience, NICHD. She and her group studies the cell biology of endocrine and neuroendocrine cells, focusing on the mechanisms of biosynthesis and intracellular trafficking of peptide hormones and neuropeptides and their processing enzymes, the regulation of dense-core secretory granule biogenesis, and the physiological roles of the prohormone processing enzyme carboxypeptidase E, and peptides derived from the neuroendocrine protein, chromogranin A. Her studies have elucidated molecular mechanisms governing protein trafficking to the regulated secretory pathway and identified players and mechanisms that control secretory granule biogenesis and transport in endocrine and neuroendocrine cells and neurons. Her research has also provided a better understanding of diseases such as diabetes, obesity and neurodegeneration. Recently, she and her team have discovered a splice isoform of the enzyme, carboxypeptidase E (CPE-ΔN) that is highly expressed in different types of metastatic tumor cells and is an inducer of tumor growth and metastasis. Clinical studies so far have shown that CPE-∆N is a very promising powerful biomarker for predicting future metastasis, and a potential therapeutic _target for different malignant cancers.
This page is archived
Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.
Kim E et al.2023 Nov 15
Latest recommendation by:
16 Jan 2024
- Interesting Hypothesis
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease.
Lopes JR et al.2023 Sep 12
Latest recommendation by:
16 Jan 2024
- Interesting Hypothesis
2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer's resilience.
Kumar A et al.2023 Sep 20
Latest recommendation by:
16 Jan 2024
- Interesting Hypothesis